CSF concentrations of total tau (t-tau), amyloid-β 1 to 42 peptide (Aβ1–42) and tau phosphorylated at the threonine 181 (p-tau181p) are considered to be CSF biomarkers which are diagnostic for AD [6], [16], [17]. Here, MAPT is linked to Alzheimer disease.